The FDA approves e-cigarettes to help addicted adult smokers

  • The Food and Drug Administration said the e-cigarette reduces exposure to harmful chemicals.
  • E-cigarette aerosols are “significantly less toxic” than its alternatives, the FDA found.
  • The manufacturer must comply with requirements to reduce youth exposure to the product.

The story was created Tuesday when the U.S. Food and Drug Administration issued its first-ever approval of an e-cigarette, Vuse Solo by RJ Reynolds Vapor Company, and two accompanying tobacco-flavored e-liquid belts.

“Manufacturer’s data show that its tobacco-flavored products can benefit addicted adult smokers who switch to these products – either completely or with a significant reduction in cigarette consumption – by reducing their exposure to harmful chemicals,” said Mitch Zeller, director of the FDA’s Center for Tobacco products, it appears in a press release.

During the evaluation of the products, the FDA found that aerosols in e-cigarettes are “significantly less toxic” than for flammable cigarettes, according to the agency’s press release. In addition, the agency determined that the potential benefit of the e-cigarette to smokers would outweigh the risks to young people if its manufacturer, RJ Reynolds Vapor Company, follows requirements to reduce youth exposure and access to the products.

The agency also recognized the 2021 National Youth Tobacco Survey, which found about 10% of high school students who used e-cigarettes named Vuse as their usual brand. In the press release, the FDA cited data that found that most teens and young adults who use e-cigarettes started using flavors such as fruit, candy, and mint, which reinforced its decision to approve tobacco products.

“These data reinforce the FDA’s decision to approve tobacco products because these products are less attractive to young people, and approval of these products may be beneficial for adult incinerated cigarette users who completely switch to electronic nicotine delivery systems or reduce their cigarette consumption significantly,” the FDA said in a statement. Press release.

Leave a Comment